Skip to content
Subscriber Only
Opinion
Max Nisen

Eli Lilly Wants You to Know Its Price Hikes Don't Work

Other drugmakers could benefit from its transparent approach.

The drug-pricing debate focuses too much on President Donald Trump's Twitter account, and too little on the fact that price hikes don't work that well any more. 

According to a report it released Monday, Eli Lilly & Co. had a 50-percent-off sale on its drugs in the U.S. in 2016, giving half the list price of its medicines back to insurers and pharmacy benefit managers, on average. It raised list prices by 14 percent, but only received 2.4 percent of that increase.